TGEN - Targeted Genetics Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TGEN - Targeted Genetics Corporation

TGEN 9.300

+0.6%

12:52 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (334)	5/27/2001 4:38:14 AM
From: Mike McFarland	Read Replies (1) of 557

Nature 411, 385-389 Haematopoietic cell transplantation as immunotherapy FREDERICK R. APPELBAUM Clinical Research Division, Fred Hutchinson Cancer Research Center nature.com Acknowledgements include Greenberg and Riddell, the sort of scientists that I would guess could show up on the CellExSys SAB one day. fhcrc.org CellExSys targen.com I would like to think that isn't mere fluff--it reads great for newbies, but the area is obviously exceedingly complicated and the summary on the web is merely a teaser.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next